Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units)

Journal of Hospital Infection

Volumn 64, Issue 3, 2006, Pages 238-243

  Meyer, E ^a   Schwab, F ^b,d   Gastmeier, P ^c,d   Rueden, H ^b,d   Daschner, F D ^a,d   Jonas, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d National Reference Centre for Surveillance of Nosocomial Infections   (Germany)

Author keywords

Antibiotic use; ICU; Stenotrophomonas maltophilia; Surveillance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; IMIDAZOLE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG USE; GERMANY; HOSPITAL; HOSPITAL BED; HOSPITAL INFECTION; HOSPITAL LABORATORY; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; INFECTION RISK; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MULTIPLE REGRESSION; NONHUMAN; POPULATION DENSITY; QUALITY CONTROL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION REVIEW; FLUOROQUINOLONES; GERMANY; GLYCOPEPTIDES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; RISK FACTORS; SENTINEL SURVEILLANCE; STENOTROPHOMONAS MALTOPHILIA;

EID: 33749246410     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.07.006     Document Type: Article

References (19)

1. Denton M., and Kerr K.G. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11 (1998) 57-80
2. Muder R.R., Harris A.P., and Muller S. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 22 (1996) 508-512
3. Calza L., Manfredi R., and Chiodo F. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection 31 (2003) 155-161
4. Steinkamp G., Wiedemann B., and Rietschel E. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros 4 (2005) 41-48
5. von Graevenitz A., and Bucher C. Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods. J Clin Microbiol 18 (1983) 983-985
6. Kerr K.G., Corps C.M., and Hawkey P.M. Infections due to Xanthomonas maltophilia in patients with hematologic malignancy. Rev Infect Dis 13 (1991) 762
7. Apisarnthanarak A., Fraser V.J., Dunne W.M., et al. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea. Clin Infect Dis 37 (2003) 1131-1135
8. Clark N.M., Patterson J., and Lynch III J.P. Antimicrobial resistance among Gram-negative organisms in the intensive care unit. Curr Opin Crit Care 9 (2003) 413-423
9. Wang W.S., Liu C.P., Lee C.M., et al. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37 (2004) 359-365
10. Sanyal S.C., and Mokaddas E.M. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 11 (1999) 28-33
11. Elting L.S., Khardori N., Bodey G.P., et al. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 11 (1990) 134-138
12. Carmeli Y., and Samore M.H. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 24 (1997) 1131-1134
13. Schaumann R., Stein K., Eckhardt C., et al. Infections caused by Stenotrophomonas maltophilia - a prospective study. Infection 29 (2001) 205-208
14. Van Couwenberghe C.J., Farver T.B., and Cohen S.H. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol 18 (1997) 316-321
15. Meyer E., Jonas D., Schwab F., et al. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31 (2003) 208-215
16. Sader H.S., and Jones R.N. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25 (2005) 95-109
17. Schwaber M.J., De Medina T., and Carmeli Y. Epidemiological interpretation of antibiotic resistance studies - what are we missing?. Nat Rev Microbiol 2 (2004) 979-983
18. Raffenberg M., Szymanski T., Lubasch A., et al. Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care patients - a prospective case-control study. Dtsch Med Wochenschr 126 (2001) 514-518
19. Vartivarian S.E., Papadakis K.A., Palacios J.A., et al. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann Intern Med 121 (1994) 969-973